Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
Neurodegenerative diseases, encompassing conditions like Alzheimer's and Parkinson's, share a commonality the accumulation of misfolded proteins leading to brain cell death. The precise link between protein aggregates and neurodegeneration remains unclear. Professor at Ruhr University Bochumdiscovered that misfolded prion proteins can deactivate TDP-43(TAR DNA-binding protein 43), crucial for maintaining protein balance, especially in nerve cells. Conditions like Alzheimer's and Parkinson's are characterized by these misfolded proteins, leading to cellular dysfunction and eventual cell death. The ongoing debate within the scientific community revolves around understanding the nature of these harmful protein species and their selective targeting of specific neurons.
Neurodegenerative diseases, ranging from Alzheimer's to prion diseases, exhibit protein misfolding and deposits in the brain. While it's established that misfolded proteins contribute to these diseases, debates persist on the nature of harmful protein species and how they selectively damage specific neurons. Two mechanisms are recognized: misfolding can make the protein toxic or lead to a loss of its physiological function, disrupting vital cell processes.
TDP-43 (TAR DNA-binding protein 43) plays a crucial role in translating genetic information into proteins and maintaining balance in nerve cells. In patients with conditions like amyotrophic lateral sclerosis, TDP-43 clumping is observed. Prion diseases, initiated by misfolded prion proteins, include Creutzfeldt-Jakob disease. The study revealed that misfolded prion proteins induce clumping and inactivation of TDP-43, impacting its splicing activity and altering protein expression.
Misfolded prion proteins were found to interact with TDP-43, leading to TDP aggregates. This interaction reduces TDP-43-dependent splicing activity in the cell nucleus, resulting in changed protein expression. The research indicates a partnership between prion proteins and TDP-43 in neurodegenerative diseases, shedding light on how disease-associated prion proteins impact signaling pathways through cross-seeding. Brain samples from Creutzfeld-Jakob patients demonstrated TDP-43 aggregates alongside prion protein deposits, revealing a novel mechanism in neurodegenerative pathways.